Genitourinary Cancer

Genitourinary Cancer

20 items identified
A031801: Advanced Renal Cell Carcinoma with Bone Metastasis
Alliance-A031704/PDIGREE (Renal Cell Cancer)
AMG 509 in patients with mCRPC (Prostate Cancer)
CG0070 in NMIBC Unresponsive to BCG - BOND-003 (Bladder Cancer)
CHAMP (Prostate Cancer)
Coping Together-2 (Cancer Support)
CRSP-ONC-005 (Solid Tumors)
Expand URO (Genitourinary Cancers that Require Surgery)
FEATURES OF PRIMARY AND ADAPTIVE IMMUNOTHERAPY RESISTANCE IN MICROSATELLITE INSTABLE CANCERS
Intravesical Enfortumab Vedotin in Non-Muscle Invasive Bladder Cancer
Keynote B15 - EV/Pembro vs GEM/CIS in muscle-invasive bladder cancer
Merck Prostate 365 - Combination therapies for mCRPC (Prostate Cancer)
Merck U03B: Targeted combination therapies for second line ccRCC patients (Renal Cell Cancer)
NRG-GU009 (Prostate Cancer)
OncoCHAT (Advanced Solid Cancer)
Propella: Intramuscular abiraterone decanoate for metastatic prostate cancer
Stellar-002: XL-092 (Kidney, Bladder, and Prostate Cancer)
Synthekine STK-012 (Solid Tumors)
TAR-200/Cetrelimab vs. chemoradiotherapy in MIBC (Bladder Cancer)
Tyra SURF-301: Phase 1/2 study for patients with urothelial carcinoma and an FGFR3 alteration